[HTML][HTML] Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential

E Saus, S Iraola-Guzmán, JR Willis… - Molecular aspects of …, 2019 - Elsevier
The gastrointestinal tract harbors most of the microbiota associated with humans. In recent
years, there has been a surge of interest in assessing the relationships between the gut …

A review on human fecal metabolomics: Methods, applications and the human fecal metabolome database

N Karu, L Deng, M Slae, AC Guo, T Sajed, H Huynh… - Analytica chimica …, 2018 - Elsevier
Metabolomic analysis of human biospecimens had progressed quickly over the past
decade. Technological and methodological advances have led to the comprehensive …

[HTML][HTML] Application of metagenomics in the human gut microbiome

WL Wang, SY Xu, ZG Ren, L Tao… - World journal of …, 2015 - ncbi.nlm.nih.gov
There are more than 1000 microbial species living in the complex human intestine. The gut
microbial community plays an important role in protecting the host against pathogenic …

Gut microbiome in chronic kidney disease: challenges and opportunities

A Nallu, S Sharma, A Ramezani, J Muralidharan… - Translational …, 2017 - Elsevier
More than 100 trillion microbial cells that reside in the human gut heavily influence nutrition,
metabolism, and immune function of the host. Gut dysbiosis, seen commonly in patients with …

Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery

S Patel, S Ahmed - Journal of pharmaceutical and biomedical analysis, 2015 - Elsevier
Most cancers are lethal and metabolic alterations are considered a hallmark of this deadly
disease. Genomics and proteomics have contributed vastly to understand cancer biology …

Odors and cancer: Current status and future directions

F Gouzerh, JM Bessière, B Ujvari, F Thomas… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Cancer is the second leading cause of death in the world. Because tumors detected at early
stages are easier to treat, the search for biomarkers—especially non-invasive ones—that …

Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool

DG Brown, S Rao, TL Weir, J O'Malia, M Bazan… - Cancer & …, 2016 - Springer
Background Colorectal cancers (CRC) are associated with perturbations in cellular amino
acids, nucleotides, pentose-phosphate pathway carbohydrates, and glycolytic …

[HTML][HTML] Microbial markers in colorectal cancer detection and/or prognosis

R Villéger, A Lopès, J Veziant, J Gagnière… - World journal of …, 2018 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the second leading cause of cancer worldwide. CRC is still
associated with a poor prognosis among patients with advanced disease. On the contrary …

Microbiome-mediated fructose depletion restricts murine gut colonization by vancomycin-resistant Enterococcus

S Isaac, A Flor-Duro, G Carruana… - Nature …, 2022 - nature.com
Multidrug-resistant organisms (MDRO) are a major threat to public health. MDRO infections,
including those caused by vancomycin-resistant Enterococcus (VRE), frequently begin by …

[HTML][HTML] Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review

F Zhang, Y Zhang, W Zhao, K Deng, Z Wang, C Yang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) remains an incurable disease. There are no effective noninvasive
techniques that have achieved colorectal cancer (CRC) diagnosis, prognosis, survival and …